What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Lewis B. Silverman spends much of his time researching Acute lymphocytic leukemia, Internal medicine, Surgery, Chemotherapy and Cancer research.
His Acute lymphocytic leukemia research is multidisciplinary, incorporating elements of Childhood Acute Lymphoblastic Leukemia, Incidence and Acute leukemia.
The Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
The various areas that he examines in his Surgery study include Clinical trial and Asparaginase.
His biological study spans a wide range of topics, including Pediatrics and Dexrazoxane.
His studies deal with areas such as Mutation, Fms-Like Tyrosine Kinase 3, Leukemia and Tumor suppressor gene as well as Cancer research.
His most cited work include:
- Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia (2273 citations)
- Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. (671 citations)
- Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia (511 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Oncology, Acute lymphocytic leukemia, Surgery and Cancer research are his primary areas of study.
His research links Gastroenterology with Internal medicine.
His research in Oncology focuses on subjects like Lymphoblastic Leukemia, which are connected to Pediatrics, Dana-Farber Cancer Institute and Toxicity.
His Acute lymphocytic leukemia research incorporates themes from Hematopoietic stem cell transplantation, Chemotherapy regimen, Incidence, Hematology and Acute leukemia.
His work carried out in the field of Surgery brings together such families of science as Asparaginase and Dexrazoxane.
His Cancer research study combines topics from a wide range of disciplines, such as Mutation, Apoptosis, T cell, Transcription factor and Leukemia.
He most often published in these fields:
- Internal medicine (67.98%)
- Oncology (30.62%)
- Acute lymphocytic leukemia (28.09%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (67.98%)
- Oncology (30.62%)
- Cancer research (26.69%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Oncology, Cancer research, Lymphoblastic Leukemia and Childhood Acute Lymphoblastic Leukemia.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Gastroenterology.
The concepts of his Gastroenterology study are interwoven with issues in Chemotherapy, Cumulative incidence and Dexamethasone.
His Cancer research research includes elements of T cell, Transcription factor, Germline, EZH2 and Leukemia.
His research on Childhood Acute Lymphoblastic Leukemia concerns the broader Immunology.
His research integrates issues of Chemotherapy regimen and Immune system in his study of Acute lymphocytic leukemia.
Between 2016 and 2021, his most popular works were:
- Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with philadelphia chromosome–positive acute lymphoblastic leukemia: Results of children’s oncology group trial AALL0622 (86 citations)
- Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia (69 citations)
- Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study (51 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary areas of study are Internal medicine, Cancer research, Minimal residual disease, Gastroenterology and Transplantation.
Chemotherapy, Clinical trial, Cancer, Induction chemotherapy and Vincristine are subfields of Internal medicine in which his conducts study.
The Cancer research study combines topics in areas such as T cell, Transcription factor, Targeted therapy, Leukemia and PTCH1.
The concepts of his Gastroenterology study are interwoven with issues in Cumulative dose, Surgery, Childhood Acute Lymphoblastic Leukemia and Odds ratio.
His Transplantation research includes elements of CRISPR, Pharmacogenomics, Immunology and Lymphoblastic Leukemia.
The various areas that he examines in his Imatinib mesylate study include Dasatinib and Acute lymphocytic leukemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
